Survey of adolescents' needs and parents' views on sexual health in juvenile idiopathic arthritis.

Adolescents Healthcare providers Juvenile idiopathic arthritis Parents Patient education Sexual health

Journal

Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897

Informations de publication

Date de publication:
05 Sep 2023
Historique:
received: 06 06 2023
accepted: 28 08 2023
medline: 7 9 2023
pubmed: 6 9 2023
entrez: 5 9 2023
Statut: epublish

Résumé

Although the advent of new therapeutics for juvenile idiopathic arthritis (JIA) patients has considerably lessened the impact of the disease and reduced its sequelae, the outcomes of JIA remain important in their lives. Disease repercussions and side effects of treatments may affect sexual health and cause psychological distress. This aim of the study was to determine the expectations of adolescent JIA patients and the perceptions of their parents regarding knowledge and communication with healthcare providers (HCPs) in the field of sexual health (SH). In France, from September 2021 to April 2022, a survey was conducted, using anonymous self-administered questionnaires, among JIA patients (adults (aged 18-45 years) to provide insights from their recollection of their adolescence) and their parents in nine rheumatology centers and three patient associations. The responses to the 76 patient questionnaires and 43 parent questionnaires that were collected were analyzed. Half of the patients thought JIA impacted their romantic relationships, but the results were less clear-cut for their sexual activity; and 58.7% of the patients said they would be comfortable discussing the subject with HCPs, but only 26.3% had done so, mainly regarding biomedical issues. The patients and their parents thought that ideally, the topic should be addressed in an individual patient education session at the hospital (51.3% and 34.9%, respectively), in a regular consultation (47.4% and 53.5%), or in a dedicated consultation requested by the adolescent without the adolescent's parents being informed (38.2% and 20.9%). Most of the respondents thought HCPs should be proactive in SH (77.6% of the patients and 69.8% of their parents). More patients than parents said the following digital information tools must be used: videos (29.0% vs. 9.3%, p = 0.0127) and smartphone applications (25.0% vs. 9.3%, p = 0.0372). HCPs should consider addressing the unmet need for SH discussions during their patient encounters. To meet this need, we propose concrete actions in line with the wishes of patients and parents. NCT04791189.

Sections du résumé

BACKGROUND BACKGROUND
Although the advent of new therapeutics for juvenile idiopathic arthritis (JIA) patients has considerably lessened the impact of the disease and reduced its sequelae, the outcomes of JIA remain important in their lives. Disease repercussions and side effects of treatments may affect sexual health and cause psychological distress. This aim of the study was to determine the expectations of adolescent JIA patients and the perceptions of their parents regarding knowledge and communication with healthcare providers (HCPs) in the field of sexual health (SH).
METHODS METHODS
In France, from September 2021 to April 2022, a survey was conducted, using anonymous self-administered questionnaires, among JIA patients (adults (aged 18-45 years) to provide insights from their recollection of their adolescence) and their parents in nine rheumatology centers and three patient associations.
RESULTS RESULTS
The responses to the 76 patient questionnaires and 43 parent questionnaires that were collected were analyzed. Half of the patients thought JIA impacted their romantic relationships, but the results were less clear-cut for their sexual activity; and 58.7% of the patients said they would be comfortable discussing the subject with HCPs, but only 26.3% had done so, mainly regarding biomedical issues. The patients and their parents thought that ideally, the topic should be addressed in an individual patient education session at the hospital (51.3% and 34.9%, respectively), in a regular consultation (47.4% and 53.5%), or in a dedicated consultation requested by the adolescent without the adolescent's parents being informed (38.2% and 20.9%). Most of the respondents thought HCPs should be proactive in SH (77.6% of the patients and 69.8% of their parents). More patients than parents said the following digital information tools must be used: videos (29.0% vs. 9.3%, p = 0.0127) and smartphone applications (25.0% vs. 9.3%, p = 0.0372).
CONCLUSION CONCLUSIONS
HCPs should consider addressing the unmet need for SH discussions during their patient encounters. To meet this need, we propose concrete actions in line with the wishes of patients and parents.
CLINICAL TRIAL REGISTRATION NUMBER BACKGROUND
NCT04791189.

Identifiants

pubmed: 37670340
doi: 10.1186/s12969-023-00884-x
pii: 10.1186/s12969-023-00884-x
pmc: PMC10478441
doi:

Banques de données

ClinicalTrials.gov
['NCT04791189']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95

Subventions

Organisme : Société Française de Rhumatologie
ID : Société Française de Rhumatologie

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Adv Rheumatol. 2019 Mar 22;59(1):13
pubmed: 30902114
Rheum Dis Clin North Am. 2022 Feb;48(1):113-140
pubmed: 34798942
BMJ Open. 2021 Dec 14;11(12):e052826
pubmed: 34907062
Joint Bone Spine. 2018 Jul;85(4):435-440
pubmed: 28965941
J Rheumatol. 2022 Mar;49(3):251-255
pubmed: 34782452
Int J Chronic Dis. 2016;2016:5726236
pubmed: 27656678
Clin Rheumatol. 2008 Oct;27(10):1261-5
pubmed: 18500441
J Rheumatol. 2000 Jul;27(7):1783-7
pubmed: 10914869
Rheumatol Int. 2014 May;34(5):665-8
pubmed: 23553519
J Pediatr (Rio J). 2020 Jan - Feb;96(1):100-107
pubmed: 30339783
Ann N Y Acad Sci. 2002 Jun;966:369-72
pubmed: 12114294
Eur J Epidemiol. 2001;17(11):991-9
pubmed: 12380710
J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arthritis Care Res (Hoboken). 2021 Aug;73(8):1194-1200
pubmed: 32374928
Clin Exp Rheumatol. 1998 Nov-Dec;16(6):753-6
pubmed: 9844775
J Rheumatol. 2019 Oct;46(10):1335-1344
pubmed: 30877211
Rheumatol Int. 2020 Sep;40(9):1481-1491
pubmed: 32621138
Pediatr Pulmonol. 2018 Aug;53(8):1027-1034
pubmed: 29696829
Int J Epidemiol. 1997 Aug;26(4):844-54
pubmed: 9279618
Arch Pediatr. 2003 Apr;10(4):360-6
pubmed: 12818766
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1392-404
pubmed: 22504867
J Adolesc Young Adult Oncol. 2020 Apr;9(2):222-238
pubmed: 31670579
Memory. 2017 Sep;25(8):1036-1051
pubmed: 27924682
J Rheumatol. 2009 Jun;36(6):1337-42
pubmed: 19411396
Ann Rheum Dis. 2016 Jan;75(1):190-5
pubmed: 25362042
Rheumatol Int. 2013 Aug;33(8):2045-52
pubmed: 23392772
Arthritis Rheum. 2006 Apr 15;55(2):199-207
pubmed: 16583399
J Sex Res. 2002 Aug;39(3):197-206
pubmed: 12476267
Pediatrics. 2017 Nov;140(Suppl 2):S67-S70
pubmed: 29093035
Arch Pediatr Adolesc Med. 2000 May;154(5):478-83
pubmed: 10807299
Am J Epidemiol. 1987 Feb;125(2):329-39
pubmed: 3812439
J Adv Nurs. 2000 Jul;32(1):243-8
pubmed: 10886457
Disabil Rehabil. 2005 Mar 18;27(6):293-304
pubmed: 16040531
J Clin Rheumatol. 2005 Aug;11(4):194-204
pubmed: 16357756
Turk J Med Sci. 2019 Feb 11;49(1):58-65
pubmed: 30761857
Pediatrics. 2017 Nov;140(Suppl 2):S162-S166
pubmed: 29093054
Pediatrics. 2017 Nov;140(Suppl 2):S122-S126
pubmed: 29093046
BMC Res Notes. 2015 Sep 04;8:410
pubmed: 26338674
Rev Bras Reumatol Engl Ed. 2016 Jul-Aug;56(4):323-9
pubmed: 27476625
Int J Environ Res Public Health. 2022 Mar 06;19(5):
pubmed: 35270781
Pediatrics. 2017 Nov;140(Suppl 2):S117-S121
pubmed: 29093045
Body Image. 2013 Mar;10(2):141-8
pubmed: 23219705
Rheumatol Ther. 2016 Dec;3(2):187-207
pubmed: 27747582
Rheumatology (Oxford). 2002 Dec;41(12):1428-35
pubmed: 12468825
Int J Environ Res Public Health. 2021 Jan 09;18(2):
pubmed: 33435342

Auteurs

Carine Savel (C)

CRECHE Unit, Department of Pediatrics, INSERM CIC 1405, CHU Clermont-Ferrand, 1 place Lucie & Raymond Aubrac, Clermont-Ferrand, 63100, France. csavel@chu-clermontferrand.fr.
Department of Public Health, CHU Clermont-Ferrand, Clermont-Ferrand, France. csavel@chu-clermontferrand.fr.

Aurélie Chausset (A)

CRECHE Unit, Department of Pediatrics, INSERM CIC 1405, CHU Clermont-Ferrand, 1 place Lucie & Raymond Aubrac, Clermont-Ferrand, 63100, France.
Research on Healthcare Performance (RESHAPE), INSERM U1290, Claude Bernard University Lyon 1, Lyon, France.

Pauline Berland (P)

Transversal Patient Education Unit, Department of Public Health, CHU Clermont-Ferrand, Clermont- Ferrand, France.

Candy Guiguet-Auclair (C)

Department of Public Health, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Laura Cabane (L)

Rheumatology Department, CHU Nice, Nice, France.

Bruno Fautrel (B)

Service de Rhumatologie, Sorbonne Université, AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.

Philippe Gaudin (P)

University Grenoble Alpes, T-RAIG, TIMC-IMAG, CNRS UMR 5525, Grenoble, France.
Department of Rheumatology, Grenoble Alpes University Hospital, Échirolles, Grenoble, France.

Pascale Guillot (P)

Rheumatology Department, Nantes University Hospital, 1 place Alexis Ricordeau, Nantes, France.

Gilles Hayem (G)

Rheumatology Department, Paris Saint-Joseph Hospital, Paris, France.

Delphine Lafarge (D)

Association France Spondyloarthrites (AFS), Tulle, France.

Etienne Merlin (E)

CRECHE Unit, Department of Pediatrics, INSERM CIC 1405, CHU Clermont-Ferrand, 1 place Lucie & Raymond Aubrac, Clermont-Ferrand, 63100, France.
Department of Pediatrics, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Nadine Pezière (N)

Association Kourir, Paris, France.

Christelle Sordet (C)

Department of Rheumatology, National Reference Center for Systemic Autoimmune Diseases (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Sonia Trope (S)

Association Nationale de Défense Contre l'Arthrite Rhumatoïde (ANDAR), Paris, France.

Anne Tournadre (A)

Rheumatology, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Sandrine Malochet (S)

Rheumatology, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Jean-David Cohen (JD)

Rheumatology Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH